Grant Abbott Laboratories Transaction History

Grant

$170 Million
Q1 2025

A detailed history of Grant transactions in Abbott Laboratories stock. As of the latest transaction made, Grant holds 9,098 shares of ABT stock, worth $1.18 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares

9,098

Previous 9,098 -0.0%

Holding current value

$1.18 Million

Previous $1.03 Million 17.2%

% of portfolio

0.71%

Previous 0.58%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 15, 2025	SELL	$111.93 - $119.39 $45,107 - $48,114	-403 Reduced 4.24%	9,098 $1.03 Million
Q3 2024 Oct 15, 2024	SELL	$100.07 - $118.13 $13,009 - $15,356	-130 Reduced 1.35%	9,501 $1.08 Million
Q2 2024 Jul 22, 2024	SELL	$100.73 - $112.44 $1,813 - $2,023	-18 Reduced 0.19%	9,631 $1 Million
Q1 2024 Apr 25, 2024	SELL	$109.52 - $120.96 $306,327 - $338,325	-2,797 Reduced 22.47%	9,649 $1.1 Million
Q4 2023 Jan 30, 2024	BUY	$90.19 - $110.4 $34,993 - $42,835	388 Added 3.22%	12,446 $1.37 Million

Q3 2023 Oct 24, 2023	BUY	$95.53 - $114.62 $286 - $343	3 Added 0.02%	12,058 $1.17 Million
Q2 2023 Jul 19, 2023	BUY	$100.78 - $112.29 $101,989 - $113,637	1,012 Added 9.16%	12,055 $1.31 Million
Q1 2023 May 01, 2023	SELL	$96.86 - $114.01 $1,162 - $1,368	-12 Reduced 0.11%	11,043 $1.12 Million
Q4 2022 Jan 10, 2023	BUY	$95.06 - $111.52 $190 - $223	2 Added 0.02%	11,055 $0
Q3 2022 Nov 02, 2022	BUY	$96.76 - $112.03 $51,766 - $59,936	535 Added 5.09%	11,053 $1.08 Million
Q1 2022 Apr 25, 2022	BUY	$114.02 - $139.04 $62,711 - $76,472	550 Added 5.52%	10,518 $1.26 Million
Q4 2020 Jan 15, 2021	BUY	$105.0 - $114.42 $1.05 Million - $1.14 Million	9,968 New	9,968 $1.12 Million

Others Institutions Holding ABT

# of Institutions

3,653

Shares Held

1.38B

Call Options Held

10.4M

Put Options Held

9.01M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $228B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grant, based on Form 13F filings with the SEC.

News

Stay updated on Grant with notifications on news.

Account